Category: News

Boston magazine’s 2020 list of “Top Doctors” recognizes 47 Department of Surgery faculty members. Congratulations to the following providers for being recognized as “tops” in their respective fields:

Colon and Rectal Surgery
Ronald Bleday, MD
Christian Corwin, MD
Joel Goldberg, MD

Otolaryngology
Donald Annino, MD

Plastic Surgery
Matthew Carty, MD
Yoon Chun, MD
Charles Hergrueter, MD
Dennis Orgill, MD, PhD
Bohdan Pomahac, MD
Andrea Pusic, MD
Christian Sampson, MD
Simon Talbot, MD

Surgery
Stanley Ashley, MD
Monica Bertagnolli, MD
Katherina Calvillo, MD
Thomas Clancy, MD
Gerard Doherty, MD
Margaret Duggan, MD
Atul Gawande, MD
Mehra Golshan, MD, MBA
Pardon Kenney, MD
Tari King, MD
Sayeed Malek, MD
Francis D. Moore, Jr., MD
Faina Nakhlis, MD
Chandrajit Raut, MD
Esther Rhei, MD
Scott Shikora, MD
Douglas Smink, MD, MPH
Ali Tavakkoli, MD
Ashley Vernon, MD

Thoracic and Cardiac Surgery
Raphael Bueno, MD
Christopher Ducko, MD
Hari Mallidi, MD
Steven Mentzer, MD
Scott Swanson, MD
Jon Wee, MD
Daniel Wiener, MD

Urology
Steven Chang, MD
Adam Kibel, MD
Michael Malone, MD
Michael O’Leary, MD, MPH
Graeme Steele, MD

Vascular Surgery
Michael Belkin, MD
Edwin Gravereaux, MD
Matthew Menard, MD
Charles Ozaki, MD

---

This year, the magazine highlighted 1,665 physicians in 66 different specialties as exemplary leaders in their respective fields. To prepare the annual list, Boston magazine partners with Castle Connolly Medical Ltd., a health care research group, and invites physicians and medical leadership of leading hospitals to identify highly skilled, exceptional doctors in the region. Castle Connolly’s physician-led team of researchers rigorously screens the nominated physicians to select those most highly regarded by their peers.

---

Dr. Preston has been awarded a $774K award from the U.S. Army Medical Research Acquisition Activity for his study: “PSA level during midlife and undiagnosed prostate cancer at autopsy: Understanding tumor biology and racial disparities.”

The study aims to develop smarter screening strategies to accurately identify men at risk for developing advanced prostate cancer while minimizing harms by testing mid-life PSA levels. The study will obtain blood from autopsies of black and white men to assess how PSA in midlife relates to pre-diagnosis natural history of prostate cancer and to determine when racial differences manifest in the natural history of prostate cancer.

Mark Preston, MD, MPH 

Mark A. Preston, MD, is a urologic surgeon at Brigham and Women’s Hospital and assistant professor of surgery at Harvard Medical School. Dr. Preston received his medical degree from the University of Ottawa in Canada, where he also completed his residency training in Urology. He completed a three-year accredited fellowship in Urologic Oncology at Massachusetts General Hospital including a master of public health from the Harvard T.H. Chan School of Public Health with a concentration in clinical effectiveness. He is board certified in Urology.

Dr. Preston’s clinical interests include urologic oncology (bladder, kidney, prostate and testicular cancer) and minimally invasive surgery. Dr. Preston’s research focuses on the epidemiology of prostate and kidney cancer risk with an emphasis on predictive biomarkers and pharmacoepidemiology.

C. Keith Ozaki, MD, has been appointed vice chair of the Department of Surgery at Brigham Health, effective January 1, 2020. In this new role, Keith will serve as a senior member of the Department of Surgery leadership team.

C. Keith Ozaki, MD
Vice Chair, Department of Surgery, Brigham and Women’s Hospital
John A. Mannick Professor of Surgery, Brigham and Women’s Hospital
Professor of Surgery, Harvard Medical School

Dr. C. Keith Ozaki is a clinically active vascular surgeon, vice chair of the Department of Surgery and the John A. Mannick Professor of Surgery at Brigham and Women’s Hospital. He is a professor of surgery at Harvard Medical School.

He earned his medical degree from Duke University School of Medicine, completed a general surgery residency through the Deaconess/Harvard Surgical Service (now Beth Israel Deaconess Medical Center) and then graduated from the vascular surgery fellowship at the University of Michigan Health System. He serves as director of vascular surgery research at the Brigham and currently leads the Ozaki Vascular Biology Lab within the Division of Vascular and Endovascular Surgery. Dr. Ozaki is also the director of resident research in the Department of Surgery. In this role, he prepares surgical trainees for their two to three years of academic enrichment time embedded in their surgical residency.

Dr. Ozaki’s clinical interests include complex hemodialysis access and peripheral vascular occlusive disease. He has authored over 120 peer-reviewed publications.